Matthew K Fust's Net Worth
Estimate Recalculated Nov 7, 2024 04:44PM EST
Who is Matthew K Fust
Matthew K Fust has an estimated net worth of $26.3 Million. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., MACROGENICS INC, Atara Biotherapeutics, Inc., Crinetics Pharmaceuticals, Inc., JAZZ PHARMACEUTICALS INC, Ultragenyx Pharmaceutical Inc., Dermira, Inc., and ONYX PHARMACEUTICALS INC.
SEC CIK
Matthew K Fust's CIK is 0001397266
Past Insider Trading and Trends
2024 was Matthew K Fust's most active year for acquiring shares with 15 total transactions. Matthew K Fust's most active month to acquire stocks was the month of May. 2013 was Matthew K Fust's most active year for disposing of shares, totalling 26 transactions. Matthew K Fust's most active month to dispose stocks was the month of January. 2012 saw Matthew K Fust paying a total of $808,831.84 for 95,508 shares, this is the most they've acquired in one year. In 2013 Matthew K Fust cashed out on 318,107 shares for a total of $9,843,680.97, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
